Members: Vincristine, Vinblastine, Vinorelbine, Vindesine

Class: Plant alkaloids (derived from Catharanthus roseus / Madagascar periwinkle).

Mechanism:

  • Bind to β-tubulin, preventing microtubule polymerization.
  • Block mitotic spindle formation → M-phase cell cycle arrest → apoptosis.

Comparison Table: Vinca Alkaloids

Drug (Brand) Major Indications Dose-Limiting Toxicity Other Toxicities Key Pearls
Vincristine (Oncovin®) ALL, NHL, HL, Wilmstumor, neuroblastoma, rhabdomyosarcoma, MM Neurotoxicity (peripheral, autonomic, cranial) SIADH, constipation/ileus, alopecia, vesicant, minimal myelosuppression Max dose 2 mg; no renal adjustment, reduce in hepatic impairment; never give IT
Vinblastine (Velban®) HL (ABVD), NHL, testicular cancer, Kaposi’s sarcoma Myelosuppression (leukopenia) Mild neurotoxicity, alopecia, GI upset, vesicant Less neuropathy vs. vincristine; dose adjust hepatic impairment
Vinorelbine (Navelbine®) NSCLC, breast cancer, ovarian cancer Myelosuppression (neutropenia) Neuropathy (mild-mod), constipation, SIADH, vesicant Oral & IV forms; monitor ANC; hepatic dose adjustment
Vindesine (not widely used; investigational in some countries) Leukemia, lymphoma, melanoma (rare use today) Myelosuppression + neurotoxicity Similar to vincristine & vinblastine Mainly used in clinical trials; not routine in NA practice

Class-wide Toxicities & Safety Issues

  • Common: Alopecia, constipation, mucositis, vesicant (extravasation → necrosis).
  • Fatal if given intrathecally (black box warning; universally lethal).
  • Metabolism: Hepatic (CYP3A4); avoid strong inhibitors (azole antifungals, macrolides, protease inhibitors).
  • Excretion: Mainly biliary → dose adjust in hepatic dysfunction (use bilirubin/AST for guidance).
  • No renal adjustment required.

Pharmacist Pearls